IMEXCO

Imexco General is a privately held, project oriented R&D based innovator. Imexco's main activities during the last two decades have been the development of medical diagnostic equipment in Neurology, Cardiology and Pain monitoring. The new Neuro-CPD is another application of Imexco's core technology for the detection and verification of chronic pain. One of its components is the FDA approved neuro-brain monitor that led to an IPO. The company is looking for M&A opportunity, a public "skeleton/shell" company, reverse merger option or a company that needs additional "content".